| Symbol |
Name |
|
AAGAB
|
alpha- and gamma-adaptin binding protein
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCC5
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 5
|
|
ABCE1
|
ATP-binding cassette, sub-family E (OABP), member 1
|
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACAD11
|
acyl-CoA dehydrogenase family, member 11
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACKR2
|
atypical chemokine receptor 2
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACSS2
|
acyl-CoA synthetase short-chain family member 2
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACTN2
|
actinin, alpha 2
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ADA
|
adenosine deaminase
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS8
|
ADAM metallopeptidase with thrombospondin type 1 motif, 8
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADCY3
|
adenylate cyclase 3
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADGRF3
|
adhesion G protein-coupled receptor F3
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
ADRBK2
|
adrenergic, beta, receptor kinase 2
|
|
AES
|
amino-terminal enhancer of split
|
|
AFAP1
|
actin filament associated protein 1
|
|
AFP
|
alpha-fetoprotein
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGFG1
|
ArfGAP with FG repeats 1
|
|
AGO1
|
argonaute RISC catalytic component 1
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGR2
|
anterior gradient 2
|
|
AGRN
|
agrin
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHRR
|
aryl-hydrocarbon receptor repressor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AIM1
|
absent in melanoma 1
|
|
AIM2
|
absent in melanoma 2
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AK1
|
adenylate kinase 1
|
|
AK7
|
adenylate kinase 7
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKR1D1
|
aldo-keto reductase family 1, member D1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALAS2
|
5'-aminolevulinate synthase 2
|
|
ALB
|
albumin
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALKBH1
|
alkB, alkylation repair homolog 1 (E. coli)
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ALPP
|
alkaline phosphatase, placental
|
|
ALS2
|
amyotrophic lateral sclerosis 2 (juvenile)
|
|
AMFR
|
autocrine motility factor receptor, E3 ubiquitin protein ligase
|
|
AMH
|
anti-Mullerian hormone
|
|
AMHR2
|
anti-Mullerian hormone receptor, type II
|
|
AMPD1
|
adenosine monophosphate deaminase 1
|
|
AMPD3
|
adenosine monophosphate deaminase 3
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL3
|
angiopoietin-like 3
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANK1
|
ankyrin 1, erythrocytic
|
|
ANO3
|
anoctamin 3
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANTXR1
|
anthrax toxin receptor 1
|
|
ANXA1
|
annexin A1
|
|
ANXA10
|
annexin A10
|
|
ANXA13
|
annexin A13
|
|
ANXA2
|
annexin A2
|
|
ANXA5
|
annexin A5
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APLNR
|
apelin receptor
|
|
APOA1
|
apolipoprotein A-I
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC1
|
apolipoprotein C-I
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AQP4
|
aquaporin 4
|
|
AQP5
|
aquaporin 5
|
|
AQP6
|
aquaporin 6, kidney specific
|
|
AR
|
androgen receptor
|
|
ARAP1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
|
|
AREG
|
amphiregulin
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARHGAP29
|
Rho GTPase activating protein 29
|
|
ARHGAP8
|
Rho GTPase activating protein 8
|
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25
|
|
ARHGEF6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARIH2
|
ariadne RBR E3 ubiquitin protein ligase 2
|
|
ARMC4
|
armadillo repeat containing 4
|
|
ARMC5
|
armadillo repeat containing 5
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ASB10
|
ankyrin repeat and SOCS box containing 10
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASF1A
|
anti-silencing function 1A histone chaperone
|
|
ASF1B
|
anti-silencing function 1B histone chaperone
|
|
ASGR1
|
asialoglycoprotein receptor 1
|
|
ASGR2
|
asialoglycoprotein receptor 2
|
|
ASPM
|
asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
|
|
ASTL
|
astacin-like metallo-endopeptidase (M12 family)
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATF3
|
activating transcription factor 3
|
|
ATF4
|
activating transcription factor 4
|
|
ATG12
|
autophagy related 12
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATMIN
|
ATM interactor
|
|
ATOH1
|
atonal homolog 1 (Drosophila)
|
|
ATOH7
|
atonal homolog 7 (Drosophila)
|
|
ATOX1
|
antioxidant 1 copper chaperone
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2B3
|
ATPase, Ca++ transporting, plasma membrane 3
|
|
ATP5A1
|
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle
|
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
|
|
ATP6V0A4
|
ATPase, H+ transporting, lysosomal V0 subunit a4
|
|
ATP6V1B1
|
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1
|
|
ATPIF1
|
ATPase inhibitory factor 1
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN2
|
ataxin 2
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AVP
|
arginine vasopressin
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
AZU1
|
azurocidin 1
|
|
B2M
|
beta-2-microglobulin
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAIAP2
|
BAI1-associated protein 2
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BANK1
|
B-cell scaffold protein with ankyrin repeats 1
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BATF
|
basic leucine zipper transcription factor, ATF-like
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BBS10
|
Bardet-Biedl syndrome 10
|
|
BBS12
|
Bardet-Biedl syndrome 12
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCAS2
|
breast carcinoma amplified sequence 2
|
|
BCKDHA
|
branched chain keto acid dehydrogenase E1, alpha polypeptide
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEX2
|
brain expressed X-linked 2
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BHLHE40
|
basic helix-loop-helix family, member e40
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BLVRA
|
biliverdin reductase A
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP1
|
bone morphogenetic protein 1
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BPIFA1
|
BPI fold containing family A, member 1
|
|
BPTF
|
bromodomain PHD finger transcription factor
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRD4
|
bromodomain containing 4
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BRK1
|
BRICK1, SCAR/WAVE actin-nucleating complex subunit
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
BSG
|
basigin (Ok blood group)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTG2
|
BTG family, member 2
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
C16ORF74
|
chromosome 16 open reading frame 74
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
C3
|
complement component 3
|
|
C3AR1
|
complement component 3a receptor 1
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
C4BPA
|
complement component 4 binding protein, alpha
|
|
C4BPB
|
complement component 4 binding protein, beta
|
|
C5
|
complement component 5
|
|
CA2
|
carbonic anhydrase II
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1D
|
calcium channel, voltage-dependent, L type, alpha 1D subunit
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1
|
|
CADM1
|
cell adhesion molecule 1
|
|
CALB2
|
calbindin 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALCR
|
calcitonin receptor
|
|
CALCRL
|
calcitonin receptor-like
|
|
CALR
|
calreticulin
|
|
CAMK1D
|
calcium/calmodulin-dependent protein kinase ID
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CANT1
|
calcium activated nucleotidase 1
|
|
CANX
|
calnexin
|
|
CAPN3
|
calpain 3, (p94)
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CARD9
|
caspase recruitment domain family, member 9
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CBX3
|
chromobox homolog 3
|
|
CBY1
|
chibby homolog 1 (Drosophila)
|
|
CCDC103
|
coiled-coil domain containing 103
|
|
CCDC114
|
coiled-coil domain containing 114
|
|
CCDC151
|
coiled-coil domain containing 151
|
|
CCDC39
|
coiled-coil domain containing 39
|
|
CCDC40
|
coiled-coil domain containing 40
|
|
CCDC7
|
coiled-coil domain containing 7
|
|
CCDC88C
|
coiled-coil domain containing 88C
|
|
CCL16
|
chemokine (C-C motif) ligand 16
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL24
|
chemokine (C-C motif) ligand 24
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL27
|
chemokine (C-C motif) ligand 27
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
|
CCNA1
|
cyclin A1
|
|
CCNB1
|
cyclin B1
|
|
CCNC
|
cyclin C
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNE2
|
cyclin E2
|
|
CCNK
|
cyclin K
|
|
CCNT1
|
cyclin T1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR4
|
chemokine (C-C motif) receptor 4
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD19
|
CD19 molecule
|
|
CD1A
|
CD1a molecule
|
|
CD200
|
CD200 molecule
|
|
CD200R1
|
CD200 receptor 1
|
|
CD209
|
CD209 molecule
|
|
CD226
|
CD226 molecule
|
|
CD24
|
CD24 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD28
|
CD28 molecule
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex)
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD5
|
CD5 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD70
|
CD70 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CD81
|
CD81 molecule
|
|
CD82
|
CD82 molecule
|
|
CD86
|
CD86 molecule
|
|
CD8A
|
CD8a molecule
|
|
CD8B
|
CD8b molecule
|
|
CD9
|
CD9 molecule
|
|
CD96
|
CD96 molecule
|
|
CDA
|
cytidine deaminase
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC34
|
cell division cycle 34
|
|
CDC37
|
cell division cycle 37
|
|
CDC6
|
cell division cycle 6
|
|
CDC73
|
cell division cycle 73
|
|
CDCP1
|
CUB domain containing protein 1
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK12
|
cyclin-dependent kinase 12
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK5RAP2
|
CDK5 regulatory subunit associated protein 2
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2B-AS1
|
CDKN2B antisense RNA 1
|
|
CDO1
|
cysteine dioxygenase type 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEACAM8
|
carcinoembryonic antigen-related cell adhesion molecule 8
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEMP1
|
cementum protein 1
|
|
CENPJ
|
centromere protein J
|
|
CEP135
|
centrosomal protein 135kDa
|
|
CEP164
|
centrosomal protein 164kDa
|
|
CEP192
|
centrosomal protein 192kDa
|
|
CERS1
|
ceramide synthase 1
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFB
|
complement factor B
|
|
CFH
|
complement factor H
|
|
CFHR1
|
complement factor H-related 1
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CGB7
|
chorionic gonadotropin, beta polypeptide 7
|
|
CHAF1A
|
chromatin assembly factor 1, subunit A (p150)
|
|
CHD5
|
chromodomain helicase DNA binding protein 5
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHP2
|
calcineurin-like EF-hand protein 2
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CISD1
|
CDGSH iron sulfur domain 1
|
|
CITED4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
|
|
CIZ1
|
CDKN1A interacting zinc finger protein 1
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CLDN1
|
claudin 1
|
|
CLDN10
|
claudin 10
|
|
CLDN11
|
claudin 11
|
|
CLDN4
|
claudin 4
|
|
CLEC16A
|
C-type lectin domain family 16, member A
|
|
CLEC2B
|
C-type lectin domain family 2, member B
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
CLN3
|
ceroid-lipofuscinosis, neuronal 3
|
|
CMA1
|
chymase 1, mast cell
|
|
CMBL
|
carboxymethylenebutenolidase homolog (Pseudomonas)
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTF
|
ciliary neurotrophic factor
|
|
CNTNAP4
|
contactin associated protein-like 4
|
|
COCH
|
cochlin
|
|
COL11A1
|
collagen, type XI, alpha 1
|
|
COL15A1
|
collagen, type XV, alpha 1
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL6A1
|
collagen, type VI, alpha 1
|
|
COL6A2
|
collagen, type VI, alpha 2
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
COL8A1
|
collagen, type VIII, alpha 1
|
|
COL8A2
|
collagen, type VIII, alpha 2
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
COQ2
|
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase
|
|
CORO1A
|
coronin, actin binding protein, 1A
|
|
CORO1C
|
coronin, actin binding protein, 1C
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CPNE1
|
copine I
|
|
CPSF6
|
cleavage and polyadenylation specific factor 6, 68kDa
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CRABP2
|
cellular retinoic acid binding protein 2
|
|
CRAT
|
carnitine O-acetyltransferase
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREB3L1
|
cAMP responsive element binding protein 3-like 1
|
|
CREBBP
|
CREB binding protein
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHBP
|
corticotropin releasing hormone binding protein
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRMP1
|
collapsin response mediator protein 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYGC
|
crystallin, gamma C
|
|
CRYGD
|
crystallin, gamma D
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSMD1
|
CUB and Sushi multiple domains 1
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CSPP1
|
centrosome and spindle pole associated protein 1
|
|
CST3
|
cystatin C
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTRC
|
chymotrypsin C (caldecrin)
|
|
CTSD
|
cathepsin D
|
|
CTSE
|
cathepsin E
|
|
CTSG
|
cathepsin G
|
|
CTSK
|
cathepsin K
|
|
CTSS
|
cathepsin S
|
|
CTTN
|
cortactin
|
|
CUBN
|
cubilin (intrinsic factor-cobalamin receptor)
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL17
|
chemokine (C-X-C motif) ligand 17
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL6
|
chemokine (C-X-C motif) ligand 6
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP46A1
|
cytochrome P450, family 46, subfamily A, polypeptide 1
|
|
CYP51A1
|
cytochrome P450, family 51, subfamily A, polypeptide 1
|
|
CYP7A1
|
cytochrome P450, family 7, subfamily A, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
CYSLTR2
|
cysteinyl leukotriene receptor 2
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAXX
|
death-domain associated protein
|
|
DAZAP1
|
DAZ associated protein 1
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DBNL
|
drebrin-like
|
|
DBT
|
dihydrolipoamide branched chain transacylase E2
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCD
|
dermcidin
|
|
DCDC2
|
doublecortin domain containing 2
|
|
DCK
|
deoxycytidine kinase
|
|
DCUN1D1
|
DCN1, defective in cullin neddylation 1, domain containing 1
|
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2
|
|
DDB2
|
damage-specific DNA binding protein 2, 48kDa
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DDR2
|
discoidin domain receptor tyrosine kinase 2
|
|
DDX1
|
DEAD (Asp-Glu-Ala-Asp) box helicase 1
|
|
DDX11
|
DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11
|
|
DDX4
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEAF1
|
DEAF1 transcription factor
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEK
|
DEK proto-oncogene
|
|
DGCR8
|
DGCR8 microprocessor complex subunit
|
|
DHCR24
|
24-dehydrocholesterol reductase
|
|
DHFR
|
dihydrofolate reductase
|
|
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLAT
|
dihydrolipoamide S-acetyltransferase
|
|
DLD
|
dihydrolipoamide dehydrogenase
|
|
DLEC1
|
deleted in lung and esophageal cancer 1
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DLX4
|
distal-less homeobox 4
|
|
DLX5
|
distal-less homeobox 5
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DMC1
|
DNA meiotic recombinase 1
|
|
DMD
|
dystrophin
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNAH1
|
dynein, axonemal, heavy chain 1
|
|
DNAH11
|
dynein, axonemal, heavy chain 11
|
|
DNAH5
|
dynein, axonemal, heavy chain 5
|
|
DNAH7
|
dynein, axonemal, heavy chain 7
|
|
DNAH8
|
dynein, axonemal, heavy chain 8
|
|
DNAI1
|
dynein, axonemal, intermediate chain 1
|
|
DNAI2
|
dynein, axonemal, intermediate chain 2
|
|
DNAL1
|
dynein, axonemal, light chain 1
|
|
DNM1
|
dynamin 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOCK2
|
dedicator of cytokinesis 2
|
|
DOCK8
|
dedicator of cytokinesis 8
|
|
DPAGT1
|
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase)
|
|
DPCD
|
deleted in primary ciliary dyskinesia homolog (mouse)
|
|
DPEP1
|
dipeptidase 1 (renal)
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DPYSL2
|
dihydropyrimidinase-like 2
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DRD5
|
dopamine receptor D5
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DSC3
|
desmocollin 3
|
|
DSG2
|
desmoglein 2
|
|
DSG3
|
desmoglein 3
|
|
DSPP
|
dentin sialophosphoprotein
|
|
DUSP23
|
dual specificity phosphatase 23
|
|
DUX4L1
|
double homeobox 4 like 1
|
|
DVL2
|
dishevelled segment polarity protein 2
|
|
DYNLT1
|
dynein, light chain, Tctex-type 1
|
|
DYSF
|
dysferlin
|
|
DYT17
|
dystonia 17
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
E2F5
|
E2F transcription factor 5, p130-binding
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EBF1
|
early B-cell factor 1
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EDN1
|
endothelin 1
|
|
EDN2
|
endothelin 2
|
|
EDN3
|
endothelin 3
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
EFHC1
|
EF-hand domain (C-terminal) containing 1
|
|
EFNA4
|
ephrin-A4
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF3E
|
eukaryotic translation initiation factor 3, subunit E
|
|
EIF3M
|
eukaryotic translation initiation factor 3, subunit M
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4ENIF1
|
eukaryotic translation initiation factor 4E nuclear import factor 1
|
|
ELAC2
|
elaC ribonuclease Z 2
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELMO1
|
engulfment and cell motility 1
|
|
ELN
|
elastin
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
|
EMP3
|
epithelial membrane protein 3
|
|
EMX2
|
empty spiracles homeobox 2
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
ENC1
|
ectodermal-neural cortex 1 (with BTB domain)
|
|
ENG
|
endoglin
|
|
ENOX1
|
ecto-NOX disulfide-thiol exchanger 1
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
ENTPD5
|
ectonucleoside triphosphate diphosphohydrolase 5
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA2
|
EPH receptor A2
|
|
EPHA5
|
EPH receptor A5
|
|
EPHA7
|
EPH receptor A7
|
|
EPHB2
|
EPH receptor B2
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
EPS8
|
epidermal growth factor receptor pathway substrate 8
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB2IP
|
erbb2 interacting protein
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERI1
|
exoribonuclease 1
|
|
ERLIN2
|
ER lipid raft associated 2
|
|
ERO1L
|
ERO1-like (S. cerevisiae)
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ERVFRD-1
|
endogenous retrovirus group FRD, member 1
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ERVW-2
|
endogenous retrovirus group W, member 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRG
|
estrogen-related receptor gamma
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV6
|
ets variant 6
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EXO1
|
exonuclease 1
|
|
EXOC5
|
exocyst complex component 5
|
|
EXOC6B
|
exocyst complex component 6B
|
|
EXT2
|
exostosin glycosyltransferase 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP6
|
fatty acid binding protein 6, ileal
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FAM134C
|
family with sequence similarity 134, member C
|
|
FAM167A
|
family with sequence similarity 167, member A
|
|
FAM3B
|
family with sequence similarity 3, member B
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCF
|
Fanconi anemia, complementation group F
|
|
FANCG
|
Fanconi anemia, complementation group G
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBLN5
|
fibulin 5
|
|
FBN1
|
fibrillin 1
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCAR
|
Fc fragment of IgA receptor
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FCRL3
|
Fc receptor-like 3
|
|
FDCSP
|
follicular dendritic cell secreted protein
|
|
FFAR3
|
free fatty acid receptor 3
|
|
FGA
|
fibrinogen alpha chain
|
|
FGB
|
fibrinogen beta chain
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF18
|
fibroblast growth factor 18
|
|
FGF19
|
fibroblast growth factor 19
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FGFRL1
|
fibroblast growth factor receptor-like 1
|
|
FGG
|
fibrinogen gamma chain
|
|
FHIT
|
fragile histidine triad
|
|
FIG4
|
FIG4 phosphoinositide 5-phosphatase
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
|
FKBP1B
|
FK506 binding protein 1B, 12.6 kDa
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FLCN
|
folliculin
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FMOD
|
fibromodulin
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FNBP4
|
formin binding protein 4
|
|
FNDC3B
|
fibronectin type III domain containing 3B
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXA1
|
forkhead box A1
|
|
FOXA2
|
forkhead box A2
|
|
FOXC1
|
forkhead box C1
|
|
FOXC2
|
forkhead box C2
|
|
FOXE3
|
forkhead box E3
|
|
FOXL2
|
forkhead box L2
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP1
|
forkhead box P1
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FPR1
|
formyl peptide receptor 1
|
|
FPR2
|
formyl peptide receptor 2
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTL
|
ferritin, light polypeptide
|
|
FTMT
|
ferritin mitochondrial
|
|
FUCA1
|
fucosidase, alpha-L- 1, tissue
|
|
FUS
|
FUS RNA binding protein
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FUT5
|
fucosyltransferase 5 (alpha (1,3) fucosyltransferase)
|
|
FUT6
|
fucosyltransferase 6 (alpha (1,3) fucosyltransferase)
|
|
FXN
|
frataxin
|
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GADD45GIP1
|
growth arrest and DNA-damage-inducible, gamma interacting protein 1
|
|
GALNT13
|
polypeptide N-acetylgalactosaminyltransferase 13
|
|
GAS6
|
growth arrest-specific 6
|
|
GAST
|
gastrin
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GATA6
|
GATA binding protein 6
|
|
GBA
|
glucosidase, beta, acid
|
|
GCG
|
glucagon
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCM1
|
glial cells missing homolog 1 (Drosophila)
|
|
GCM2
|
glial cells missing homolog 2 (Drosophila)
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF2
|
growth differentiation factor 2
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GFER
|
growth factor, augmenter of liver regeneration
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GGCT
|
gamma-glutamylcyclotransferase
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRH
|
growth hormone releasing hormone
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIPC1
|
GIPC PDZ domain containing family, member 1
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJC2
|
gap junction protein, gamma 2, 47kDa
|
|
GJD3
|
gap junction protein, delta 3, 31.9kDa
|
|
GLB1
|
galactosidase, beta 1
|
|
GLC1C
|
glaucoma 1, open angle, C
|
|
GLC1H
|
glaucoma 1, open angle, H (adult-onset)
|
|
GLC3C
|
glaucoma 3, primary congenital, C
|
|
GLCE
|
glucuronic acid epimerase
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLRX3
|
glutaredoxin 3
|
|
GLS
|
glutaminase
|
|
GLTP
|
glycolipid transfer protein
|
|
GMDS
|
GDP-mannose 4,6-dehydratase
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNAL
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNLY
|
granulysin
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GOLM1
|
golgi membrane protein 1
|
|
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP1BB
|
glycoprotein Ib (platelet), beta polypeptide
|
|
GP5
|
glycoprotein V (platelet)
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GP9
|
glycoprotein IX (platelet)
|
|
GPBAR1
|
G protein-coupled bile acid receptor 1
|
|
GPC1
|
glypican 1
|
|
GPC3
|
glypican 3
|
|
GPHN
|
gephyrin
|
|
GPR183
|
G protein-coupled receptor 183
|
|
GPR26
|
G protein-coupled receptor 26
|
|
GPR35
|
G protein-coupled receptor 35
|
|
GPRC6A
|
G protein-coupled receptor, class C, group 6, member A
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX3
|
glutathione peroxidase 3
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRHL3
|
grainyhead-like 3 (Drosophila)
|
|
GRHPR
|
glyoxylate reductase/hydroxypyruvate reductase
|
|
GRIA3
|
glutamate receptor, ionotropic, AMPA 3
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GUCY2C
|
guanylate cyclase 2C
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H1FX
|
H1 histone family, member X
|
|
H2AFX
|
H2A histone family, member X
|
|
HACE1
|
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAS2
|
hyaluronan synthase 2
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBB
|
hemoglobin, beta
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC11
|
histone deacetylase 11
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC9
|
histone deacetylase 9
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HFE
|
hemochromatosis
|
|
HFM1
|
HFM1, ATP-dependent DNA helicase homolog (S. cerevisiae)
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HHIP
|
hedgehog interacting protein
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIP1
|
huntingtin interacting protein 1
|
|
HIP1R
|
huntingtin interacting protein 1 related
|
|
HIST1H1A
|
histone cluster 1, H1a
|
|
HIST1H3D
|
histone cluster 1, H3d
|
|
HIVEP2
|
human immunodeficiency virus type I enhancer binding protein 2
|
|
HIVEP3
|
human immunodeficiency virus type I enhancer binding protein 3
|
|
HK2
|
hexokinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMG20B
|
high mobility group 20B
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1A-AS1
|
HNF1A antisense RNA 1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HNRNPF
|
heterogeneous nuclear ribonucleoprotein F
|
|
HNRNPH1
|
heterogeneous nuclear ribonucleoprotein H1 (H)
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HOGA1
|
4-hydroxy-2-oxoglutarate aldolase 1
|
|
HOPX
|
HOP homeobox
|
|
HOTAIR
|
HOX transcript antisense RNA
|
|
HOXA1
|
homeobox A1
|
|
HOXA10
|
homeobox A10
|
|
HOXA9
|
homeobox A9
|
|
HOXB7
|
homeobox B7
|
|
HOXB8
|
homeobox B8
|
|
HOXC13
|
homeobox C13
|
|
HP
|
haptoglobin
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HPSE
|
heparanase
|
|
HPX
|
hemopexin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRK
|
harakiri, BCL2 interacting protein
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
HSD3B2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA1L
|
heat shock 70kDa protein 1-like
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HSPE1
|
heat shock 10kDa protein 1
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HTT
|
huntingtin
|
|
HYAL1
|
hyaluronoglucosaminidase 1
|
|
HYAL2
|
hyaluronoglucosaminidase 2
|
|
IAPP
|
islet amyloid polypeptide
|
|
IBSP
|
integrin-binding sialoprotein
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM3
|
intercellular adhesion molecule 3
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IDO2
|
indoleamine 2,3-dioxygenase 2
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFITM3
|
interferon induced transmembrane protein 3
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL3
|
interferon, lambda 3
|
|
IFNLR1
|
interferon, lambda receptor 1
|
|
IGBP1
|
immunoglobulin (CD79A) binding protein 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFALS
|
insulin-like growth factor binding protein, acid labile subunit
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IKZF2
|
IKAROS family zinc finger 2 (Helios)
|
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos)
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL12A
|
interleukin 12A
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL13
|
interleukin 13
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL17D
|
interleukin 17D
|
|
IL17F
|
interleukin 17F
|
|
IL18
|
interleukin 18
|
|
IL18BP
|
interleukin 18 binding protein
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL23R
|
interleukin 23 receptor
|
|
IL24
|
interleukin 24
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL3
|
interleukin 3
|
|
IL31
|
interleukin 31
|
|
IL31RA
|
interleukin 31 receptor A
|
|
IL32
|
interleukin 32
|
|
IL33
|
interleukin 33
|
|
IL4
|
interleukin 4
|
|
IL4I1
|
interleukin 4 induced 1
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
IL9R
|
interleukin 9 receptor
|
|
ING1
|
inhibitor of growth family, member 1
|
|
ING4
|
inhibitor of growth family, member 4
|
|
INHA
|
inhibin, alpha
|
|
INHBB
|
inhibin, beta B
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INPP5E
|
inositol polyphosphate-5-phosphatase, 72 kDa
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
INS-IGF2
|
INS-IGF2 readthrough
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INSM1
|
insulinoma-associated 1
|
|
INSR
|
insulin receptor
|
|
IQCB1
|
IQ motif containing B1
|
|
IQSEC1
|
IQ motif and Sec7 domain 1
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRAK3
|
interleukin-1 receptor-associated kinase 3
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRF8
|
interferon regulatory factor 8
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS4
|
insulin receptor substrate 4
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITGB5
|
integrin, beta 5
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
JAG1
|
jagged 1
|
|
JAG2
|
jagged 2
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JAM3
|
junctional adhesion molecule 3
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KAT7
|
K(lysine) acetyltransferase 7
|
|
KCNC4
|
potassium channel, voltage gated Shaw related subfamily C, member 4
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ12
|
potassium channel, inwardly rectifying subfamily J, member 12
|
|
KCNJ14
|
potassium channel, inwardly rectifying subfamily J, member 14
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ4
|
potassium channel, inwardly rectifying subfamily J, member 4
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNJ8
|
potassium channel, inwardly rectifying subfamily J, member 8
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNN3
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KCNRG
|
potassium channel regulator
|
|
KDR
|
kinase insert domain receptor
|
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3
|
|
KIAA0226L
|
KIAA0226-like
|
|
KIDINS220
|
kinase D-interacting substrate, 220kDa
|
|
KIF14
|
kinesin family member 14
|
|
KIF1A
|
kinesin family member 1A
|
|
KIF20A
|
kinesin family member 20A
|
|
KIF6
|
kinesin family member 6
|
|
KIF7
|
kinesin family member 7
|
|
KIFC1
|
kinesin family member C1
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KISS1R
|
KISS1 receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KL
|
klotho
|
|
KLF1
|
Kruppel-like factor 1 (erythroid)
|
|
KLF17
|
Kruppel-like factor 17
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLK1
|
kallikrein 1
|
|
KLK11
|
kallikrein-related peptidase 11
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK6
|
kallikrein-related peptidase 6
|
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT14
|
keratin 14, type I
|
|
KRT15
|
keratin 15, type I
|
|
KRT18
|
keratin 18, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT7
|
keratin 7, type II
|
|
KRT75
|
keratin 75, type II
|
|
KRT8
|
keratin 8, type II
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAMA5
|
laminin, alpha 5
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
LARP7
|
La ribonucleoprotein domain family, member 7
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LCT
|
lactase
|
|
LDHA
|
lactate dehydrogenase A
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS13
|
lectin, galactoside-binding, soluble, 13
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS3BP
|
lectin, galactoside-binding, soluble, 3 binding protein
|
|
LGALS7
|
lectin, galactoside-binding, soluble, 7
|
|
LGMN
|
legumain
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LIMD1
|
LIM domains containing 1
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LIN9
|
lin-9 DREAM MuvB core complex component
|
|
LMAN1
|
lectin, mannose-binding, 1
|
|
LMNA
|
lamin A/C
|
|
LMNB1
|
lamin B1
|
|
LOX
|
lysyl oxidase
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LOXL3
|
lysyl oxidase-like 3
|
|
LPL
|
lipoprotein lipase
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
|
LRRC6
|
leucine rich repeat containing 6
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LRRN4
|
leucine rich repeat neuronal 4
|
|
LSM14A
|
LSM14A, SCD6 homolog A (S. cerevisiae)
|
|
LTA
|
lymphotoxin alpha
|
|
LTBP2
|
latent transforming growth factor beta binding protein 2
|
|
LTF
|
lactotransferrin
|
|
LUM
|
lumican
|
|
LY96
|
lymphocyte antigen 96
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MACC1
|
metastasis associated in colon cancer 1
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
|
|
MAG
|
myelin associated glycoprotein
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAGEC1
|
melanoma antigen family C1
|
|
MAGEC2
|
melanoma antigen family C2
|
|
MAGED2
|
melanoma antigen family D2
|
|
MAGI3
|
membrane associated guanylate kinase, WW and PDZ domain containing 3
|
|
MALAT1
|
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
|
|
MALT1
|
MALT1 paracaspase
|
|
MAML1
|
mastermind-like 1 (Drosophila)
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2
|
microtubule-associated protein 2
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAP4K2
|
mitogen-activated protein kinase kinase kinase kinase 2
|
|
MAP4K3
|
mitogen-activated protein kinase kinase kinase kinase 3
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MATN3
|
matrilin 3
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MBD4
|
methyl-CpG binding domain protein 4
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MBOAT4
|
membrane bound O-acyltransferase domain containing 4
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC2R
|
melanocortin 2 receptor (adrenocorticotropic hormone)
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCFD2
|
multiple coagulation factor deficiency 2
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MCM3
|
minichromosome maintenance complex component 3
|
|
MCM6
|
minichromosome maintenance complex component 6
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MCPH1
|
microcephalin 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED12
|
mediator complex subunit 12
|
|
MEFV
|
Mediterranean fever
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEP1A
|
meprin A, alpha (PABA peptide hydrolase)
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFHAS1
|
malignant fibrous histiocytoma amplified sequence 1
|
|
MFN2
|
mitofusin 2
|
|
MFRP
|
membrane frizzled-related protein
|
|
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase)
|
|
MGLL
|
monoglyceride lipase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIA
|
melanoma inhibitory activity
|
|
MICAL3
|
microtubule associated monooxygenase, calponin and LIM domain containing 3
|
|
MICU1
|
mitochondrial calcium uptake 1
|
|
MID1
|
midline 1
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MILR1
|
mast cell immunoglobulin-like receptor 1
|
|
MIR106B
|
microRNA 106b
|
|
MIR10A
|
microRNA 10a
|
|
MIR10B
|
microRNA 10b
|
|
MIR122
|
microRNA 122
|
|
MIR125A
|
microRNA 125a
|
|
MIR132
|
microRNA 132
|
|
MIR137
|
microRNA 137
|
|
MIR138-1
|
microRNA 138-1
|
|
MIR138-2
|
microRNA 138-2
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR148A
|
microRNA 148a
|
|
MIR151A
|
microRNA 151a
|
|
MIR152
|
microRNA 152
|
|
MIR155
|
microRNA 155
|
|
MIR155HG
|
MIR155 host gene
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR182
|
microRNA 182
|
|
MIR184
|
microRNA 184
|
|
MIR18A
|
microRNA 18a
|
|
MIR192
|
microRNA 192
|
|
MIR195
|
microRNA 195
|
|
MIR199A1
|
microRNA 199a-1
|
|
MIR199A2
|
microRNA 199a-2
|
|
MIR200B
|
microRNA 200b
|
|
MIR205
|
microRNA 205
|
|
MIR20B
|
microRNA 20b
|
|
MIR21
|
microRNA 21
|
|
MIR215
|
microRNA 215
|
|
MIR218-1
|
microRNA 218-1
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR2861
|
microRNA 2861
|
|
MIR29C
|
microRNA 29c
|
|
MIR30E
|
microRNA 30e
|
|
MIR31
|
microRNA 31
|
|
MIR34A
|
microRNA 34a
|
|
MIR34B
|
microRNA 34b
|
|
MIR34C
|
microRNA 34c
|
|
MIR409
|
microRNA 409
|
|
MIR424
|
microRNA 424
|
|
MIR497
|
microRNA 497
|
|
MIR504
|
microRNA 504
|
|
MIR506
|
microRNA 506
|
|
MIR552
|
microRNA 552
|
|
MIR592
|
microRNA 592
|
|
MIR760
|
microRNA 760
|
|
MIR92B
|
microRNA 92b
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MIRLET7A3
|
microRNA let-7a-3
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MKS1
|
Meckel syndrome, type 1
|
|
MLANA
|
melan-A
|
|
MLF1
|
myeloid leukemia factor 1
|
|
MLH1
|
mutL homolog 1
|
|
MLX
|
MLX, MAX dimerization protein
|
|
MLXIP
|
MLX interacting protein
|
|
MLYCD
|
malonyl-CoA decarboxylase
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP21
|
matrix metallopeptidase 21
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPDZ
|
multiple PDZ domain protein
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSLN
|
mesothelin
|
|
MST1
|
macrophage stimulating 1
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MSX2
|
msh homeobox 2
|
|
MT-ATP6
|
ATP synthase F0 subunit 6
|
|
MT-ND4
|
NADH dehydrogenase, subunit 4 (complex I)
|
|
MT-ND5
|
NADH dehydrogenase, subunit 5 (complex I)
|
|
MT-ND6
|
NADH dehydrogenase, subunit 6 (complex I)
|
|
MT-TA
|
tRNA
|
|
MT-TL1
|
tRNA
|
|
MT1F
|
metallothionein 1F
|
|
MTA1
|
metastasis associated 1
|
|
MTA2
|
metastasis associated 1 family, member 2
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MUM1
|
melanoma associated antigen (mutated) 1
|
|
MUTYH
|
mutY homolog
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH1
|
myosin, heavy chain 1, skeletal muscle, adult
|
|
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow
|
|
MYL3
|
myosin, light chain 3, alkali; ventricular, skeletal, slow
|
|
MYLIP
|
myosin regulatory light chain interacting protein
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYOD1
|
myogenic differentiation 1
|
|
NAGS
|
N-acetylglutamate synthase
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NANOGP8
|
Nanog homeobox pseudogene 8
|
|
NANOS3
|
nanos homolog 3 (Drosophila)
|
|
NAPSA
|
napsin A aspartic peptidase
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
ND1
|
|
|
NDN
|
necdin, melanoma antigen (MAGE) family member
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDRG2
|
NDRG family member 2
|
|
NEFH
|
neurofilament, heavy polypeptide
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NEFM
|
neurofilament, medium polypeptide
|
|
NEK2
|
NIMA-related kinase 2
|
|
NES
|
nestin
|
|
NEU1
|
sialidase 1 (lysosomal sialidase)
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFE2L3
|
nuclear factor, erythroid 2-like 3
|
|
NFIB
|
nuclear factor I/B
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIE
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NHLRC1
|
NHL repeat containing E3 ubiquitin protein ligase 1
|
|
NISCH
|
nischarin
|
|
NKIRAS1
|
NFKB inhibitor interacting Ras-like 1
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-2
|
NK2 homeobox 2
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NME8
|
NME/NM23 family member 8
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOG
|
noggin
|
|
NOL3
|
nucleolar protein 3 (apoptosis repressor with CARD domain)
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NOV
|
nephroblastoma overexpressed
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NPHP1
|
nephronophthisis 1 (juvenile)
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPR3
|
natriuretic peptide receptor 3
|
|
NPRL2
|
nitrogen permease regulator-like 2 (S. cerevisiae)
|
|
NPTX2
|
neuronal pentraxin II
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NR2E1
|
nuclear receptor subfamily 2, group E, member 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRF1
|
nuclear respiratory factor 1
|
|
NRG1
|
neuregulin 1
|
|
NRG2
|
neuregulin 2
|
|
NRP1
|
neuropilin 1
|
|
NSUN2
|
NOP2/Sun RNA methyltransferase family, member 2
|
|
NTF4
|
neurotrophin 4
|
|
NTM
|
neurotrimin
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUMB
|
numb homolog (Drosophila)
|
|
NUP210
|
nucleoporin 210kDa
|
|
NUS1
|
nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae)
|
|
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa
|
|
OASL
|
2'-5'-oligoadenylate synthetase-like
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
ODF2
|
outer dense fiber of sperm tails 2
|
|
OFD1
|
oral-facial-digital syndrome 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
ONECUT1
|
one cut homeobox 1
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPRL1
|
opiate receptor-like 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OPTC
|
opticin
|
|
OPTN
|
optineurin
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORAI2
|
ORAI calcium release-activated calcium modulator 2
|
|
ORAI3
|
ORAI calcium release-activated calcium modulator 3
|
|
OSBP
|
oxysterol binding protein
|
|
OSCAR
|
osteoclast associated, immunoglobulin-like receptor
|
|
OSMR
|
oncostatin M receptor
|
|
OSTM1
|
osteopetrosis associated transmembrane protein 1
|
|
OXTR
|
oxytocin receptor
|
|
P2RX3
|
purinergic receptor P2X, ligand gated ion channel, 3
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
P2RY8
|
purinergic receptor P2Y, G-protein coupled, 8
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PADI2
|
peptidyl arginine deiminase, type II
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAFAH1B2
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa)
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PAK6
|
p21 protein (Cdc42/Rac)-activated kinase 6
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX2
|
paired box 2
|
|
PAX6
|
paired box 6
|
|
PAX8
|
paired box 8
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCGF2
|
polycomb group ring finger 2
|
|
PCK2
|
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
|
|
PCM1
|
pericentriolar material 1
|
|
PCMTD1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDE8A
|
phosphodiesterase 8A
|
|
PDE8B
|
phosphodiesterase 8B
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDHX
|
pyruvate dehydrogenase complex, component X
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PDK2
|
pyruvate dehydrogenase kinase, isozyme 2
|
|
PDK3
|
pyruvate dehydrogenase kinase, isozyme 3
|
|
PDK4
|
pyruvate dehydrogenase kinase, isozyme 4
|
|
PDPN
|
podoplanin
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PELO
|
pelota homolog (Drosophila)
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PGD
|
phosphogluconate dehydrogenase
|
|
PGF
|
placental growth factor
|
|
PGK1
|
phosphoglycerate kinase 1
|
|
PGM3
|
phosphoglucomutase 3
|
|
PGR
|
progesterone receptor
|
|
PHF20
|
PHD finger protein 20
|
|
PIBF1
|
progesterone immunomodulatory binding factor 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIK3R2
|
phosphoinositide-3-kinase, regulatory subunit 2 (beta)
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PIP
|
prolactin-induced protein
|
|
PIP5K1A
|
phosphatidylinositol-4-phosphate 5-kinase, type I, alpha
|
|
PITX2
|
paired-like homeodomain 2
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive)
|
|
PKM
|
pyruvate kinase, muscle
|
|
PKP2
|
plakophilin 2
|
|
PLA2G1B
|
phospholipase A2, group IB (pancreas)
|
|
PLA2G3
|
phospholipase A2, group III
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
|
PLAC1
|
placenta-specific 1
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLEKHA7
|
pleckstrin homology domain containing, family A member 7
|
|
PLEKHB1
|
pleckstrin homology domain containing, family B (evectins) member 1
|
|
PLIN1
|
perilipin 1
|
|
PLIN2
|
perilipin 2
|
|
PLIN3
|
perilipin 3
|
|
PLK1
|
polo-like kinase 1
|
|
PLOD2
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2
|
|
PLP1
|
proteolipid protein 1
|
|
PLXNC1
|
plexin C1
|
|
PLXND1
|
plexin D1
|
|
PMCH
|
pro-melanin-concentrating hormone
|
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1
|
|
PML
|
promyelocytic leukemia
|
|
PMM2
|
phosphomannomutase 2
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
POC1B
|
POC1 centriolar protein B
|
|
PODXL
|
podocalyxin-like
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLL
|
polymerase (DNA directed), lambda
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POTED
|
POTE ankyrin domain family, member D
|
|
POU2AF1
|
POU class 2 associating factor 1
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1R2
|
protein phosphatase 1, regulatory (inhibitor) subunit 2
|
|
PPP1R2P9
|
protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
|
PPP4R1
|
protein phosphatase 4, regulatory subunit 1
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRC1
|
protein regulator of cytokinesis 1
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDX2
|
peroxiredoxin 2
|
|
PREP
|
prolyl endopeptidase
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCDBP
|
protein kinase C, delta binding protein
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PRNP
|
prion protein
|
|
PROK1
|
prokineticin 1
|
|
PROKR1
|
prokineticin receptor 1
|
|
PROM1
|
prominin 1
|
|
PROX1
|
prospero homeobox 1
|
|
PRSS2
|
protease, serine, 2 (trypsin 2)
|
|
PRSS3
|
protease, serine, 3
|
|
PRSS56
|
protease, serine, 56
|
|
PRTN3
|
proteinase 3
|
|
PSAP
|
prosaposin
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSMB1
|
proteasome (prosome, macropain) subunit, beta type, 1
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES2
|
prostaglandin E synthase 2
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK6
|
protein tyrosine kinase 6
|
|
PTMA
|
prothymosin, alpha
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRG
|
protein tyrosine phosphatase, receptor type, G
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O
|
|
PTPRU
|
protein tyrosine phosphatase, receptor type, U
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PTTG1IP
|
pituitary tumor-transforming 1 interacting protein
|
|
PTX3
|
pentraxin 3, long
|
|
PVALB
|
parvalbumin
|
|
PVR
|
poliovirus receptor
|
|
PYCARD
|
PYD and CARD domain containing
|
|
PYY
|
peptide YY
|
|
RAB14
|
RAB14, member RAS oncogene family
|
|
RAB5A
|
RAB5A, member RAS oncogene family
|
|
RAB6C
|
RAB6C, member RAS oncogene family
|
|
RAB8A
|
RAB8A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RAD23A
|
RAD23 homolog A (S. cerevisiae)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAG1
|
recombination activating gene 1
|
|
RAG2
|
recombination activating gene 2
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASL11B
|
RAS-like, family 11, member B
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF10
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 10
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RB1
|
retinoblastoma 1
|
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBM3
|
RNA binding motif (RNP1, RRM) protein 3
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
|
RECQL4
|
RecQ protein-like 4
|
|
REG1A
|
regenerating islet-derived 1 alpha
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELN
|
reelin
|
|
REN
|
renin
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RFWD2
|
ring finger and WD repeat domain 2, E3 ubiquitin protein ligase
|
|
RFX3
|
regulatory factor X, 3 (influences HLA class II expression)
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RHOA
|
ras homolog family member A
|
|
RHOC
|
ras homolog family member C
|
|
RHOH
|
ras homolog family member H
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RIPK3
|
receptor-interacting serine-threonine kinase 3
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase
|
|
RNF20
|
ring finger protein 20, E3 ubiquitin protein ligase
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RP2
|
retinitis pigmentosa 2 (X-linked recessive)
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RPRM
|
reprimo, TP53 dependent G2 arrest mediator candidate
|
|
RPS14
|
ribosomal protein S14
|
|
RPS19
|
ribosomal protein S19
|
|
RPS24
|
ribosomal protein S24
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPSA
|
ribosomal protein SA
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RSAD2
|
radical S-adenosyl methionine domain containing 2
|
|
RSPH1
|
radial spoke head 1 homolog (Chlamydomonas)
|
|
RSPO2
|
R-spondin 2
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A11
|
S100 calcium binding protein A11
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A6
|
S100 calcium binding protein A6
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100P
|
S100 calcium binding protein P
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
S1PR5
|
sphingosine-1-phosphate receptor 5
|
|
SAFB
|
scaffold attachment factor B
|
|
SAFB2
|
scaffold attachment factor B2
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SAMD8
|
sterile alpha motif domain containing 8
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SCARA3
|
scavenger receptor class A, member 3
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCGB2A2
|
secretoglobin, family 2A, member 2
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SCNN1G
|
sodium channel, non voltage gated 1 gamma subunit
|
|
SCO2
|
SCO2 cytochrome c oxidase assembly protein
|
|
SCUBE1
|
signal peptide, CUB domain, EGF-like 1
|
|
SCX
|
scleraxis basic helix-loop-helix transcription factor
|
|
SDC1
|
syndecan 1
|
|
SDC2
|
syndecan 2
|
|
SDC4
|
syndecan 4
|
|
SDHAF2
|
succinate dehydrogenase complex assembly factor 2
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SEC14L2
|
SEC14-like 2 (S. cerevisiae)
|
|
SELE
|
selectin E
|
|
SELL
|
selectin L
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SELPLG
|
selectin P ligand
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
|
|
SEMG1
|
semenogelin I
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7
|
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SET
|
SET nuclear proto-oncogene
|
|
SETD2
|
SET domain containing 2
|
|
SFN
|
stratifin
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP5
|
secreted frizzled-related protein 5
|
|
SFTPD
|
surfactant protein D
|
|
SGCA
|
sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SH3BP2
|
SH3-domain binding protein 2
|
|
SHH
|
sonic hedgehog
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SIAE
|
sialic acid acetylesterase
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain
|
|
SIGLEC1
|
sialic acid binding Ig-like lectin 1, sialoadhesin
|
|
SIGLEC7
|
sialic acid binding Ig-like lectin 7
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIRT1
|
sirtuin 1
|
|
SIRT3
|
sirtuin 3
|
|
SIRT6
|
sirtuin 6
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLAMF7
|
SLAM family member 7
|
|
SLC10A1
|
solute carrier family 10 (sodium/bile acid cotransporter), member 1
|
|
SLC10A2
|
solute carrier family 10 (sodium/bile acid cotransporter), member 2
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6
|
|
SLC13A5
|
solute carrier family 13 (sodium-dependent citrate transporter), member 5
|
|
SLC15A2
|
solute carrier family 15 (oligopeptide transporter), member 2
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC17A5
|
solute carrier family 17 (acidic sugar transporter), member 5
|
|
SLC17A6
|
solute carrier family 17 (vesicular glutamate transporter), member 6
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5
|
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC22A12
|
solute carrier family 22 (organic anion/urate transporter), member 12
|
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC23A1
|
solute carrier family 23 (ascorbic acid transporter), member 1
|
|
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC26A6
|
solute carrier family 26 (anion exchanger), member 6
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC29A4
|
solute carrier family 29 (equilibrative nucleoside transporter), member 4
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC31A1
|
solute carrier family 31 (copper transporter), member 1
|
|
SLC34A3
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 3
|
|
SLC39A1
|
solute carrier family 39 (zinc transporter), member 1
|
|
SLC39A3
|
solute carrier family 39 (zinc transporter), member 3
|
|
SLC3A1
|
solute carrier family 3 (amino acid transporter heavy chain), member 1
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLC4A10
|
solute carrier family 4, sodium bicarbonate transporter, member 10
|
|
SLC4A2
|
solute carrier family 4 (anion exchanger), member 2
|
|
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4
|
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1
|
|
SLC5A8
|
solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8
|
|
SLC6A12
|
solute carrier family 6 (neurotransmitter transporter), member 12
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLCO2A1
|
solute carrier organic anion transporter family, member 2A1
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMC4
|
structural maintenance of chromosomes 4
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SMPD2
|
sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase)
|
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SNRNP35
|
small nuclear ribonucleoprotein 35kDa (U11/U12)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOCS6
|
suppressor of cytokine signaling 6
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SORBS2
|
sorbin and SH3 domain containing 2
|
|
SORT1
|
sortilin 1
|
|
SOST
|
sclerostin
|
|
SOX17
|
SRY (sex determining region Y)-box 17
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP110
|
SP110 nuclear body protein
|
|
SP3
|
Sp3 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPAST
|
spastin
|
|
SPDEF
|
SAM pointed domain containing ETS transcription factor
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related)
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRY4
|
sprouty homolog 4 (Drosophila)
|
|
SPTAN1
|
spectrin, alpha, non-erythrocytic 1
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SREBF2
|
sterol regulatory element binding transcription factor 2
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SRP19
|
signal recognition particle 19kDa
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
SRY
|
sex determining region Y
|
|
SS18L1
|
synovial sarcoma translocation gene on chromosome 18-like 1
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
SSRP1
|
structure specific recognition protein 1
|
|
SSTR1
|
somatostatin receptor 1
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSTR5
|
somatostatin receptor 5
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
|
ST13
|
suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)
|
|
ST18
|
suppression of tumorigenicity 18, zinc finger
|
|
ST2
|
suppression of tumorigenicity 2
|
|
ST3GAL4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
|
|
ST7
|
suppression of tumorigenicity 7
|
|
STARD3
|
StAR-related lipid transfer (START) domain containing 3
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STBMS1
|
Strabismus, susceptibility to, 1
|
|
STIL
|
SCL/TAL1 interrupting locus
|
|
STIM1
|
stromal interaction molecule 1
|
|
STIM2
|
stromal interaction molecule 2
|
|
STK39
|
serine threonine kinase 39
|
|
STK4
|
serine/threonine kinase 4
|
|
STMN1
|
stathmin 1
|
|
STOML2
|
stomatin (EPB72)-like 2
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
STXBP2
|
syntaxin binding protein 2
|
|
STXBP3
|
syntaxin binding protein 3
|
|
SUFU
|
suppressor of fused homolog (Drosophila)
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SYCE1
|
synaptonemal complex central element protein 1
|
|
SYK
|
spleen tyrosine kinase
|
|
SYN1
|
synapsin I
|
|
SYNPO
|
synaptopodin
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TACR2
|
tachykinin receptor 2
|
|
TACR3
|
tachykinin receptor 3
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAPBP
|
TAP binding protein (tapasin)
|
|
TARDBP
|
TAR DNA binding protein
|
|
TASP1
|
taspase, threonine aspartase, 1
|
|
TBC1D15
|
TBC1 domain family, member 15
|
|
TBC1D3
|
TBC1 domain family, member 3
|
|
TBC1D3F
|
TBC1 domain family, member 3F
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBX21
|
T-box 21
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCF21
|
transcription factor 21
|
|
TCF3
|
transcription factor 3
|
|
TCF4
|
transcription factor 4
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TCN2
|
transcobalamin II
|
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
|
TDRD1
|
tudor domain containing 1
|
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor)
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TES
|
testin LIM domain protein
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFAP4
|
transcription factor AP-4 (activating enhancer binding protein 4)
|
|
TFDP3
|
transcription factor Dp family, member 3
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TIMM10
|
translocase of inner mitochondrial membrane 10 homolog (yeast)
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
|
TJP1
|
tight junction protein 1
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TKTL1
|
transketolase-like 1
|
|
TLN1
|
talin 1
|
|
TLN2
|
talin 2
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TM7SF2
|
transmembrane 7 superfamily member 2
|
|
TMCO1
|
transmembrane and coiled-coil domains 1
|
|
TMEFF2
|
transmembrane protein with EGF-like and two follistatin-like domains 2
|
|
TMEM173
|
transmembrane protein 173
|
|
TMEM67
|
transmembrane protein 67
|
|
TMEM97
|
transmembrane protein 97
|
|
TMPO
|
thymopoietin
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TMSB4X
|
thymosin beta 4, X-linked
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF10C
|
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
TNNI2
|
troponin I type 2 (skeletal, fast)
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNPO1
|
transportin 1
|
|
TNS4
|
tensin 4
|
|
TNXB
|
tenascin XB
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOPBP1
|
topoisomerase (DNA) II binding protein 1
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TOX2
|
TOX high mobility group box family member 2
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPK1
|
thiamin pyrophosphokinase 1
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TPM2
|
tropomyosin 2 (beta)
|
|
TPO
|
thyroid peroxidase
|
|
TPP1
|
tripeptidyl peptidase I
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRAF4
|
TNF receptor-associated factor 4
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRAP1
|
TNF receptor-associated protein 1
|
|
TRAPPC2
|
trafficking protein particle complex 2
|
|
TRD
|
T cell receptor delta locus
|
|
TRG
|
T cell receptor gamma locus
|
|
TRIM21
|
tripartite motif containing 21
|
|
TRIM22
|
tripartite motif containing 22
|
|
TRIM5
|
tripartite motif containing 5
|
|
TROVE2
|
TROVE domain family, member 2
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM5
|
transient receptor potential cation channel, subfamily M, member 5
|
|
TRPM6
|
transient receptor potential cation channel, subfamily M, member 6
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSPAN12
|
tetraspanin 12
|
|
TSPY1
|
testis specific protein, Y-linked 1
|
|
TTC21B
|
tetratricopeptide repeat domain 21B
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUBB4A
|
tubulin, beta 4A class IVa
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
TXNDC5
|
thioredoxin domain containing 5 (endoplasmic reticulum)
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TYK2
|
tyrosine kinase 2
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
UBQLN1
|
ubiquilin 1
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A10
|
UDP glucuronosyltransferase 1 family, polypeptide A10
|
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7
|
|
UGT1A8
|
UDP glucuronosyltransferase 1 family, polypeptide A8
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
ULBP1
|
UL16 binding protein 1
|
|
ULBP2
|
UL16 binding protein 2
|
|
ULBP3
|
UL16 binding protein 3
|
|
UMOD
|
uromodulin
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
UNG
|
uracil-DNA glycosylase
|
|
UPK3B
|
uroplakin 3B
|
|
UQCRC2
|
ubiquinol-cytochrome c reductase core protein II
|
|
USP11
|
ubiquitin specific peptidase 11
|
|
USP21
|
ubiquitin specific peptidase 21
|
|
USP22
|
ubiquitin specific peptidase 22
|
|
USP6
|
ubiquitin specific peptidase 6
|
|
USP7
|
ubiquitin specific peptidase 7 (herpes virus-associated)
|
|
VAC14
|
Vac14 homolog (S. cerevisiae)
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VAV2
|
vav 2 guanine nucleotide exchange factor
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VSNL1
|
visinin-like 1
|
|
VSX2
|
visual system homeobox 2
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
VWA1
|
von Willebrand factor A domain containing 1
|
|
VWA2
|
von Willebrand factor A domain containing 2
|
|
VWF
|
von Willebrand factor
|
|
WDR34
|
WD repeat domain 34
|
|
WDR36
|
WD repeat domain 36
|
|
WDR62
|
WD repeat domain 62
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WFDC1
|
WAP four-disulfide core domain 1
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WISP1
|
WNT1 inducible signaling pathway protein 1
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WNT7B
|
wingless-type MMTV integration site family, member 7B
|
|
WNT8B
|
wingless-type MMTV integration site family, member 8B
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxi |
